Skip to main content
Erschienen in: World Journal of Surgery 11/2007

01.11.2007

Efficacy and Safety of Seprafilm for Preventing Postoperative Abdominal Adhesion: Systematic Review and Meta-analysis

verfasst von: Qiqiang Zeng, Zhengping Yu, Jie You, Qiyu Zhang

Erschienen in: World Journal of Surgery | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

There is no clear consensus on the efficacy and safety of hyaluronate-carboxymethylcellulose membrane (Seprafilm) for preventing postoperative abdominal adhesion. This study is a meta-analysis of the available evidence.

Methods

A search of the MEDLINE, EMBASE, and the Cochrane Library identified eight studies that met the inclusion criteria for data extraction. Estimates of effectiveness were performed using fixed- and random-effects models. The effect was calculated as an odds ratio (OR) with 95% confidence intervals (CI) using the statistical software Review Manager Version 4.2. Level of significance was set at p < 0.05.

Results

Outcomes of 4203 patients were studied. The incidence of grade 0 adhesions among Seprafilm-treated patients was statistically significantly more than that observed among control group patients (OR 95%CI, 3.74–20.34; p < 0.01). There was no significant difference in the incidence of grade 1 adhesions between Seprafilm and control groups (OR 95%CI, 0.58–2.71; p = 0.56). The severity of grade 2 and grade 3 adhesions among Seprafilm-treated patients was significantly less than that observed among control group patients (OR 95%CI, 0.22–0.93; p = 0.03; OR 95%CI, 0.09–0.63; p < 0.01, respectively). The incidence of intestinal obstruction after abdominal surgery was not different between Seprafilm and control groups (OR 95%CI, 0.78–1.23; p = 0.84). Using Seprafilm significantly increased the incidence of abdominal abscesses (OR 95%CI, 1.06–2.54; p = 0.03) and anastomotic leaks (OR 95%CI, 1.18–3.50; p = 0.01).

Conclusions

Our systematic review and meta-analysis showed that Seprafilm could decrease abdominal adhesions after general surgery, which may benefit patients, but could not reduce postoperative intestinal obstruction. At the same time, Seprafilm did increase abdominal abscesses and anastomotic leaks.
Literatur
1.
Zurück zum Zitat Menzies D (1992) Peritoneal adhesions: incidence, cause, and prevention. Surg Annu 24(Pt 1):27–45PubMed Menzies D (1992) Peritoneal adhesions: incidence, cause, and prevention. Surg Annu 24(Pt 1):27–45PubMed
2.
Zurück zum Zitat Liakakos T, Thomakos N, Fine PM, et al. (2001) Peritoneal adhesions: etiology, pathophysiology, and clinical significance: recent advances in prevention and management. Dig Surg 18:260–273PubMedCrossRef Liakakos T, Thomakos N, Fine PM, et al. (2001) Peritoneal adhesions: etiology, pathophysiology, and clinical significance: recent advances in prevention and management. Dig Surg 18:260–273PubMedCrossRef
3.
Zurück zum Zitat Inoue M, Uchida K, Miki C, et al. (2005) Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery. J Pediatr Surg 40:1301–1306PubMedCrossRef Inoue M, Uchida K, Miki C, et al. (2005) Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery. J Pediatr Surg 40:1301–1306PubMedCrossRef
4.
Zurück zum Zitat Ray NF, Denton WG, Thamer M, et al. (1998) Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 186:1–9PubMedCrossRef Ray NF, Denton WG, Thamer M, et al. (1998) Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 186:1–9PubMedCrossRef
5.
Zurück zum Zitat Ellis H (2005) Intraabdominal and postoperative peritoneal adhesions. J Am Coll Surg 200:641–644PubMedCrossRef Ellis H (2005) Intraabdominal and postoperative peritoneal adhesions. J Am Coll Surg 200:641–644PubMedCrossRef
6.
Zurück zum Zitat Burgess L, Greenwalt K, Rowe E, et al. (1999) Evaluation of a plasticized sodium hyaluronate/carboxymethylcellulose adhesion barrier. In: Society for Biomaterials, 25th Annual Meeting Transactions, p 169 Burgess L, Greenwalt K, Rowe E, et al. (1999) Evaluation of a plasticized sodium hyaluronate/carboxymethylcellulose adhesion barrier. In: Society for Biomaterials, 25th Annual Meeting Transactions, p 169
7.
Zurück zum Zitat Eroglu A, Demirci S, Kurtman C, et al. (2001) Prevention of intra-abdominal adhesions by using Seprafilm in rats undergoing bowel resection and radiation therapy. Colorectal Dis 3:33–37PubMedCrossRef Eroglu A, Demirci S, Kurtman C, et al. (2001) Prevention of intra-abdominal adhesions by using Seprafilm in rats undergoing bowel resection and radiation therapy. Colorectal Dis 3:33–37PubMedCrossRef
8.
Zurück zum Zitat Oncel M, Remzi FH, Senagore AJ, et al. (2004) Application of Adcon-P or Seprafilm in consecutive laparotomies using a murine model. Am J Surg 187:304–308PubMedCrossRef Oncel M, Remzi FH, Senagore AJ, et al. (2004) Application of Adcon-P or Seprafilm in consecutive laparotomies using a murine model. Am J Surg 187:304–308PubMedCrossRef
9.
Zurück zum Zitat Sikkink CJ, Postma VA, Reijnen MM, et al. (2004) Hyaluronan-based antiadhesive membrane has no major effect on intraperitoneal growth of colonic tumour cells. Eur Surg Res 36:123–128PubMedCrossRef Sikkink CJ, Postma VA, Reijnen MM, et al. (2004) Hyaluronan-based antiadhesive membrane has no major effect on intraperitoneal growth of colonic tumour cells. Eur Surg Res 36:123–128PubMedCrossRef
10.
Zurück zum Zitat Tarhan OR, Eroglu A, Cetin R, et al. (2005) Effects of Seprafilm on peritoneal fibrinolytic system. ANZ J Surg 75:690–692PubMedCrossRef Tarhan OR, Eroglu A, Cetin R, et al. (2005) Effects of Seprafilm on peritoneal fibrinolytic system. ANZ J Surg 75:690–692PubMedCrossRef
11.
Zurück zum Zitat Uchida K, Urata H, Mohri Y, et al. (2005) Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response. Surg Today 35:1054–1059PubMedCrossRef Uchida K, Urata H, Mohri Y, et al. (2005) Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response. Surg Today 35:1054–1059PubMedCrossRef
12.
Zurück zum Zitat Osada H, Minai M, Tsunoda I, et al. (1999) The effect of hyaluronic acid-carboxymethylcellulose in reducing adhesion reformation in rabbits. J Int Med Res 27:292–296PubMed Osada H, Minai M, Tsunoda I, et al. (1999) The effect of hyaluronic acid-carboxymethylcellulose in reducing adhesion reformation in rabbits. J Int Med Res 27:292–296PubMed
13.
Zurück zum Zitat van Oosterom FJ, van Lanschot JJ, Oosting J, et al. (2000) Hyaluronic acid/carboxymethylcellulose membrane surrounding an intraperitoneal or subcutaneous jejunojejunostomy in rats. Eur J Surg 166:654–658PubMedCrossRef van Oosterom FJ, van Lanschot JJ, Oosting J, et al. (2000) Hyaluronic acid/carboxymethylcellulose membrane surrounding an intraperitoneal or subcutaneous jejunojejunostomy in rats. Eur J Surg 166:654–658PubMedCrossRef
14.
Zurück zum Zitat Bulbuller N, Sapmaz E, Akpolat N, et al. (2003) Effect of a bioresorbable membrane on postoperative adhesions and wound healing. J Reprod Med 48:547–550PubMed Bulbuller N, Sapmaz E, Akpolat N, et al. (2003) Effect of a bioresorbable membrane on postoperative adhesions and wound healing. J Reprod Med 48:547–550PubMed
15.
Zurück zum Zitat Burns JW, Colt MJ, Burgess LS, et al. (1997) Preclinical evaluation of Seprafilm bioresorbable menbrane. Eur J Surg 577(Suppl):40–48 Burns JW, Colt MJ, Burgess LS, et al. (1997) Preclinical evaluation of Seprafilm bioresorbable menbrane. Eur J Surg 577(Suppl):40–48
16.
Zurück zum Zitat Becker JM, Dayton MT, Fazio VW, et al. (1996) Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 183:297–306PubMed Becker JM, Dayton MT, Fazio VW, et al. (1996) Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 183:297–306PubMed
17.
Zurück zum Zitat Diamond MP (1996) Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study: Seprafilm Adhesion Study Group. Fertil Steril 66:904–910PubMed Diamond MP (1996) Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study: Seprafilm Adhesion Study Group. Fertil Steril 66:904–910PubMed
18.
Zurück zum Zitat Beck DE (1997) The role of Seprafilm bioresorbable membrane in adhesion prevention. Eur J Surg Suppl 577:49–55PubMed Beck DE (1997) The role of Seprafilm bioresorbable membrane in adhesion prevention. Eur J Surg Suppl 577:49–55PubMed
19.
Zurück zum Zitat Vrijland WW, Tseng LN, Eijkman HJ, et al. (2002) Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg 235:193–199PubMedCrossRef Vrijland WW, Tseng LN, Eijkman HJ, et al. (2002) Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg 235:193–199PubMedCrossRef
20.
Zurück zum Zitat Beck DE, Cohen Z, Fleshman JW, et al. (2003) A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 46:1310–1319PubMedCrossRef Beck DE, Cohen Z, Fleshman JW, et al. (2003) A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 46:1310–1319PubMedCrossRef
21.
Zurück zum Zitat Cohen Z, Senagore AJ, Dayton MT, et al. (2005) Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study. Dis Colon Rectum 48:1130–1139PubMedCrossRef Cohen Z, Senagore AJ, Dayton MT, et al. (2005) Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study. Dis Colon Rectum 48:1130–1139PubMedCrossRef
22.
Zurück zum Zitat Kusunoki M, Ikeuchi H, Yanagi H, et al. (2005) Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today 35:940–945PubMedCrossRef Kusunoki M, Ikeuchi H, Yanagi H, et al. (2005) Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today 35:940–945PubMedCrossRef
23.
Zurück zum Zitat Fazio VW, Cohen Z, Fleshman JW, et al. (2006) Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 49:1–11PubMedCrossRef Fazio VW, Cohen Z, Fleshman JW, et al. (2006) Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 49:1–11PubMedCrossRef
24.
Zurück zum Zitat Salum M, Wexner SD, Nogueras JJ, et al. (2006) Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol 10:187–190PubMedCrossRef Salum M, Wexner SD, Nogueras JJ, et al. (2006) Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol 10:187–190PubMedCrossRef
25.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRef Jadad AR, Moore RA, Carroll D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRef
26.
Zurück zum Zitat Moher D, Cook DJ, Eastwood S, et al. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement: quality of reporting of meta-analyses. Lancet 354:1896–1900PubMedCrossRef Moher D, Cook DJ, Eastwood S, et al. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement: quality of reporting of meta-analyses. Lancet 354:1896–1900PubMedCrossRef
27.
Zurück zum Zitat DeCherney AH, diZerega GS (1997) Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 77:671–688PubMedCrossRef DeCherney AH, diZerega GS (1997) Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 77:671–688PubMedCrossRef
28.
Zurück zum Zitat Sasaki T, Shimura H, Tanaka T, et al. (2004) Protection of trocar sites from gallbladder cancer implantation by sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) in a murine model [corrected]. Surg Endosc 18:246–251PubMedCrossRef Sasaki T, Shimura H, Tanaka T, et al. (2004) Protection of trocar sites from gallbladder cancer implantation by sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) in a murine model [corrected]. Surg Endosc 18:246–251PubMedCrossRef
29.
Zurück zum Zitat Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS, et al. (2002) The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res 63:10–14PubMedCrossRef Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS, et al. (2002) The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res 63:10–14PubMedCrossRef
30.
Zurück zum Zitat Tang CL, Seow-Choen F, Fook-Chong S, et al. (2003) Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal excision: a prospective, randomized trial. Dis Colon Rectum 46:1200–1207PubMedCrossRef Tang CL, Seow-Choen F, Fook-Chong S, et al. (2003) Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal excision: a prospective, randomized trial. Dis Colon Rectum 46:1200–1207PubMedCrossRef
Metadaten
Titel
Efficacy and Safety of Seprafilm for Preventing Postoperative Abdominal Adhesion: Systematic Review and Meta-analysis
verfasst von
Qiqiang Zeng
Zhengping Yu
Jie You
Qiyu Zhang
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9242-9

Weitere Artikel der Ausgabe 11/2007

World Journal of Surgery 11/2007 Zur Ausgabe

Letter

Reply

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.